Screener / SEC EDGAR /CIK 0001635088 /10-K filed May 20, 2026, compared with May 29, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

Roivant Sciences Ltd. ROIV

Compare with peers Embed
CEO pay, fiscal year to Mar 31, 2026

Matthew Gline was paid $3.1M as reported, $382.4M at the share price

Proxy (DEF 14A)
CEO pay, as reported $3.1M salary, bonus and awards at grant value
CEO pay, actually paid $382.4M awards valued at the share price
$100 in the shares became $561 peer group: $145
CEO pay, 4 years $216.1M down 94% while the company lost money

Did pay move with results?

Each line is 100 in 2023 · pay versus performance table, proxy (DEF 14A)

100200300 2023202420252026 CEO pay, 2023: 100CEO pay, 2024: 47CEO pay, 2025: 123CEO pay, 2026: 392 CEO pay 392 $100 invested, 2023: 100$100 invested, 2024: 143$100 invested, 2025: 137$100 invested, 2026: 377 $100 invested 377

When the pay line climbs faster than net income and the $100 line, pay rose more than results did; when it falls with them, it followed them. "Actually paid" re-values stock awards at the share price, so it moves with the stock. Numbers as the company tagged them in its proxy.

Pay against results, year by year

Pay versus performance · proxy, filed Jul 29, 2026

Fiscal year toCEOCEO pay (reported) CEO pay (actually paid) $100 became
Mar 31, 2026Matthew Gline $3.1M$382.4M $561
Mar 31, 2025Matthew Gline $163.3M$120.3M $204
Mar 31, 2024Matthew Gline $738K$45.5M $213
Mar 31, 2023Matthew Gline $49.0M$97.6M $149

Pay versus performance table of the proxy statement (DEF 14A) filed Jul 29, 2026, as tagged by the company in XBRL. Open the proxy

Pay against free cash flow per share, at peers

Change over the years each proxy covers · pay versus performance table, DEF 14A, and 10-K XBRL

CEO pay, as reported Free cash flow per share » runs past the edge. Pay is salary, bonus and awards at grant value. FCF per share is cash from operations less capital spending, over diluted shares, from the 10-K of the same fiscal year.

ROIV: CEO pay fell 94% from FY2023 to FY2026 ($49.0M to $3.1M). Open the proxy

Sources

The pay versus performance table of the latest proxy statement, as the company tagged it in XBRL.

Also

Cash & buybacks: what the company did with its cash in the same years.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ROIV/export.csv") into a cell.

Next:Crypto holdings
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.